Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 6, 2010 - Issue 4
Submit an article Journal homepage
159
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Once-daily mesalamine granules for ulcerative colitis

Garrett Lawlor Harvard Medical School, Center for Inflammatory Bowel Disease, Rose 1/East, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Center for Inflammatory Bowel Disease, Rose 1/East, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
,
Awais Ahmed Harvard Medical School, Center for Inflammatory Bowel Disease, Rose 1/East, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Center for Inflammatory Bowel Disease, Rose 1/East, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
&
Alan C Moss Harvard Medical School, Center for Inflammatory Bowel Disease, Rose 1/East, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA;[email protected]
Pages 521-526 | Published online: 10 Jan 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Maggie Ham & Alan C Moss. (2012) Mesalamine in the treatment and maintenance of remission of ulcerative colitis. Expert Review of Clinical Pharmacology 5:2, pages 113-123.
Read now
Stephen B Hanauer & Daan W Hommes. (2010) Inflammatory bowel disease. Expert Review of Clinical Immunology 6:4, pages 499-500.
Read now

Articles from other publishers (5)

Pedro M. Veloso, Raul Machado & Clarisse Nobre. (2021) Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 89-103.
Crossref
Mohammad F. Bayan & Rana F. Bayan. (2020) Recent advances in mesalamine colonic delivery systems. Future Journal of Pharmaceutical Sciences 6:1.
Crossref
Stephan Miehlke, Ahmed Madisch, Limas Kupcinskas, Dalius Petrauskas, Günter Böhm, Hans-Joachim Marks, Michael Neumeyer, Torben Nathan, Fernando Fernández-Bañares, Roland Greinwald, Ralf Mohrbacher, Michael Vieth & Ole K. Bonderup. (2014) Budesonide Is More Effective Than Mesalamine or Placebo in Short-term Treatment of Collagenous Colitis. Gastroenterology 146:5, pages 1222-1230.e2.
Crossref
Jin Lu TONG, Mei Lan HUANG, Xi Tao XU, Yu Qi QIAO & Zhi Hua RAN. (2012) Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: A meta-analysis. Journal of Digestive Diseases 13:4, pages 200-207.
Crossref
Conor Lahiff, Sunanda Kane & Alan C. Moss. (2011) Drug development in inflammatory bowel disease: The role of the FDA. Inflammatory Bowel Diseases 17:12, pages 2585-2593.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.